SCHEMBL19304151

SCHEMBL19304151

Cc1cn(C(C)(C)C)c2ncnc(Cl)c12

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LCK P06239 7/20 0.47
KDR P35968 6/20 0.47
TEK Q02763 6/20 0.47
SRC P12931 5/20 0.47
ADK P55263 1/20 0.45
RET P07949 8/20 0.39
EGFR P00533 1/20 0.39
MEN1 O00255 1/20 0.37
NR2F2 P24468 1/20 0.37
KMT2A Q03164 1/20 0.37
PI4KA P42356 1/20 0.37
PI4K2B Q8TCG2 1/20 0.37
PI4K2A Q9BTU6 1/20 0.37
PI4KB Q9UBF8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18496750 0.81 ADK (0.46) LCKKDRTEKSRCADK
SCHEMBL29589509 0.81 ADK (0.46) LCKKDRTEKSRCADK
SCHEMBL25612067 0.81 ADK (0.46) LCKKDRTEKSRCADK
SCHEMBL6935719 0.80 ADK (0.48) LCKKDRTEKSRCADK
SCHEMBL19304156 0.79 SRC (0.62) LCKKDRTEKSRCADK
SCHEMBL21178837 0.78 LCK (0.43) LCKKDRTEKSRCRET
SCHEMBL31639574 0.78 LCK (0.43) LCKKDRTEKSRCRET
SCHEMBL14725430 0.77 SRC (0.43) LCKKDRTEKSRCRET
SCHEMBL17705872 0.75 ADK (0.47) SRCADKEGFRMEN1NR2F2
SCHEMBL31639615 0.74 LCK (0.40) LCKKDRTEKSRCADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3641776-B1 ATROPISOMERISM FOR ENHANCED KINASE INHIBITOR SELECTIVITY SAN DIEGO STATE UNIV RESEARCH FOUNDATION (US) 2023-10-18 EP disclosed
EP-3269370-A1 NOVEL CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2018-01-17 EP disclosed
WO-2017146116-A1 NOVEL CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2017-08-31 WO disclosed